31st OCTOBER 

DAY 1: IMMUNE CHECKPOINT INHIBITORS

  • Approved Market Formats

  • New Agents

  • Combination Agents

CO- STIMULATORY TARGETS

  • New Developments

  • Formats and Receptors

1st NOVEMBER 

DAY 2: CELL THERAPY 

  • Antigen Targets

  • Cell Therapy for solid tumours

  • Allogeneic gene therapy

2nd NOVEMBER 

DAY 3: NOVEL THERAPIES 

  • Oncolytic viral

  • immunotherapies

  • Vaccines

VIEW THE PROGRAMME 

REGISTER HERE